Table 1. Socio-demographic and clinical characteristics of the sample.
Children 4–7 | Children 8–12 | Adolescents 13 | Parents | ||
---|---|---|---|---|---|
years-old | years-old | 18 years-old | |||
(n = 76) | (n = 159) | (n = 186) | (n = 421) | ||
Sociodemographic characteristics | |||||
Age, M (SD) | 6.06 (1.03) | 10.28 (1.46) | 14.82 (1.48) | 43.77 (17.92) | |
Sex, n (%) | Male | 44 (57.9%) | 86 (54.1%) | 117 (62.9%) | 46 (10.9%) |
Female | 32 (42.1%) | 73 (45.9%) | 69 (37–1%) | 309 (73.4%) | |
Missing | - | - | - | 66 (15.7%) | |
Country, n (%) | Sweden | 3 (3.9%) | 14 (8.8%) | 59 (31.7%) | 76 (18.1%) |
Germany | 24 (31.6%) | 41 (25.8%) | 26 (14.0%) | 91 (21.6%) | |
France | 11 (14.5%) | 30 (18.9%) | 23 (12.4%) | 64 (15.2%) | |
UK | 3 (3.9%) | 16 (10.1%) | 16 (8.6%) | 35 (8.3%) | |
Spain | 15 (19.7%) | 27 (17.0%) | 17 (9.1%) | 59 (14.0%) | |
Belgium | 12 (15.8%) | 8 (5.0%) | 19 (10.2%) | 39 (9.3%) | |
The Netherlands | 8 (10.5%) | 23 (14.5%) | 26 (14.0%) | 57 (13.5%) | |
Clinical characteristics | |||||
Diagnosis, n (%) | GHD | 28 (36.8%) | 47 (29.6%) | 77 (41.4%) | |
ISS | 48 (63.2%) | 112 (70.4%) | 109 (58.6%) | ||
Treatment status, n (%) | GH treatment | 24 (31.6%) | 71 (44.7%) | 98 (52.7%) | |
Untreated | 52 (68.4%) | 88 (55.3%) | 88 (47.3%) | ||
Current height deviation, n (%) | Above –2 SD (achieved normal height) | 27 (35.5%) | 72 (45.3%) | 92 (49.5%) | |
Below –2 SD (current short stature) | 45 (59.2%) | 84 (52.8%) | 91 (48.9%) | ||
Missing | 4 (5.3%) | 3 (1.9%) | 3 (1.6%) | ||
Patient-reported psychological problems, n (%) | Normal | - | 119 (74.8%) | 142 (76.3%) | |
Borderline | - | 17 (10.7%) | 11 (5.9%) | ||
Abnormal | - | 11 (6.9%) | 12 (6.5%) | ||
Missing | - | 12 (7.5%) | 21 (11.3%) | ||
Parent-reported psychological problems, n (%) | Normal | 41 (53.9%) | 109 (68.6%) | 138 (74.2%) | |
Borderline | 10 (13.2%) | 16 (10.1%) | 16 (8.6%) | ||
Abnormal | 22 (28.9%) | 31 (19.5%) | 28 (15.1%) | ||
Missing | 3 (3.9%) | 3 (1.9%) | 4 (2.2%) |